Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02722395 · ClinicalTrials.gov registry record

Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)

A clinical trial, sponsored by Duke University.

Completed
Registry status
5
Enrollment target

NCT02722395 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 5 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02722395 has completed, sponsored by Duke University.

COMPLETED
Registry status
5 participants
Enrollment target

Study Summary

This study is a research and development initiative established to explore the use of magnetic resonance imaging (MRI) as a tool for managing organ motion of the liver in cancer patients planning procedures for stereotactic body radiation therapy (SBRT).

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2016-08
Est. Completion 2017-02-01

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT02722395

The ClinicalTrials.gov registry entry for NCT02722395 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02722395 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02722395 about?

NCT02722395 is a clinical study titled "Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)". This study is a research and development initiative established to explore the use of magnetic resonance imaging (MRI) as a tool for managing organ motion of the liver in cancer patients planning procedures for stereotactic body radiation therapy (SBRT).

What is the current status of trial NCT02722395?

This trial is currently completed. The enrollment target is 5 participants. The study started on 2016-08. Estimated completion is 2017-02-01.

Who is sponsoring clinical trial NCT02722395?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.